Showing results (221-230 of 276) with videos related to
Sort By:
Pageof 28
Molecular Microbiology|August 1, 1993
AmpG, a signal transducer in chromosomal beta-lactamase inductionS Lindquist, K Weston-Hafer, H Schmidt, et al.Chemistry & Biology|October 30, 2012
Bacterial inactivation of the anticancer drug doxorubicinErin L Westman, Marc J Canova, Inas J Radhi, et al.Nature|June 23, 2000
Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cellsP Uhlén, A Laestadius, T Jahnukainen, et al.Voprosy Meditsinskoi Khimii|July 1, 1988
[The use of gas chromatographic profile of serum lipids for computer diagnosis]L F Lindberg, A S Mirimskiĭ, S A Popov, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 8, 2017
Electronic properties and morphology of copper oxide/n-type silicon heterostructuresP F Lindberg, S M Gorantla, A E Gunnæs, et al.The Biochemical Journal|November 1, 1986
6-beta-Iodopenicillanate as a probe for the classification of beta-lactamasesF De Meester, J M Frère, S G Waley, et al.Disease Models & Mechanisms|June 29, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cellsNicole R West, Mattias F Lindberg, Julien Dairou, et al.Journal of Pediatric Gastroenterology and Nutrition|January 1, 1982
Maturational effect of triiodothyronine and its analog 3,5-dimethyl-3'-isopropyl-L-thyronine on sucrase activity in the small intestine of the developing ratY E Vaucher, J A Anna, R F Lindberg, et al.Biorxiv : the Preprint Server for Biology|February 12, 2026
Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cellsNicole R West, Mattias F Lindberg, Julien Dairou, et al.Cancer Epidemiology|December 27, 2017
Temporal and geospatial trends of pediatric cancer incidence in Nebraska over a 24-year periodP A Farazi, S Watanabe-Galloway, L Westman, et al.Pageof 28